Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (يفتح نافذة جديدة)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Source‎: Eur J Haematol 1996;56(5):326-8.

مفهرسة‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (يفتح نافذة جديدة)

On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease. (يفتح نافذة جديدة)

el-Hazmi MA, al-Momen A, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F, Warsy AS.

Source‎: Acta Haematol 1995;94(3):128-34.

مفهرسة‎: PubMed 7502628

https://www.ncbi.nlm.nih.gov/pubmed/7502628 (يفتح نافذة جديدة)

Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. (يفتح نافذة جديدة)

Little JA, McGowan VR, Kato GJ, Partovi KS, Feld JJ, Maric I, Martyr S, Taylor JG 6th, Machado RF, Heller T, Castro O, Gladwin MT.

Source‎: Haematologica 2006;91(8):1076-83.

مفهرسة‎: PubMed 16885048

https://www.ncbi.nlm.nih.gov/pubmed/16885048 (يفتح نافذة جديدة)

Use of erythropoietin in a pregnant Jehovah's Witness with sickle-cell disease. (يفتح نافذة جديدة)

Tan TL, Ahmad H, Jhavar R, Patel R, Harrison C, Oteng-Ntim E.

Source‎: J Obstet Gynaecol 2007;27(1):82-3.

مفهرسة‎: PubMed 17365469

DOI‎: 10.1080/01443610601062739

https://www.ncbi.nlm.nih.gov/pubmed/17365469 (يفتح نافذة جديدة)

The use of barbiturate coma as salvage therapy in a postoperative Jehovah's Witness patient with life-threatening anemia. (يفتح نافذة جديدة)

Wang SW, Badami CD, Deitch EA.

Source‎: Am Surg 2009;75(12):1175-8.

مفهرسة‎: PubMed 19999907

https://www.ncbi.nlm.nih.gov/pubmed/19999907 (يفتح نافذة جديدة)